Capital Flow Monitor · Sponsors · CIK 1736153
Numerion Labs, Inc.
250 SUTTER ST. SUITE 650, SAN FRANCISCO, CA, 94108 · (650) 449-7925
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$35.0M
Sold
$19.8M
% sold
56.6%
Investors
5
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-03-19 | D ·current | 506(b) | $35.0M | $19.8M | 56.6% | 5 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Stephen Worland — Executive Officer / Director, SAN FRANCISCO, CA
- Izhar Wallach — Director, SAN FRANCISCO, CA
-
Robert Mittendorff — Director, SAN FRANCISCO, CA
3 other raises
- Solve Therapeutics, Inc. $48.2M of $120.5M · 40.0%
- Capital Rx, Inc. $230.8M of $232.9M · 99.1%
- Volastra Therapeutics, Inc. $30.1M of $30.1M · 100.0%
- Adam Seabrook — Director, SAN FRANCISCO, CA
- Linda Maxwell — Director, SAN FRANCISCO, CA
- Mike Varney — Director, SAN FRANCISCO, CA
-
Yan Zhao — Executive Officer, SAN FRANCISCO, CA
1 other raise
- Longtail Insurance Holdings Ltd. $416.2M of $750.0M · 55.5%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.